Medispa Market Australia: 13.02% Clinic Growth [2026]

Key Takeaways

• Dedicated aesthetic clinics in Australia are growing at a 13.02% CAGR through 2031, according to Mordor Intelligence’s Australia Aesthetic Devices Market report
• That’s faster than the overall Australian aesthetic devices market, which is forecast to grow at 9.83% a year from 2026 to 2031, from USD 262.24 million to USD 419.18 million
• Hospitals still hold 41.55% of the Australian aesthetic devices market in 2025, but the report flags clinics as the segment pulling revenue away from them
• Australia’s broader medical aesthetics market reached USD 396.4 million in 2025, forecast to hit USD 784.8 million by 2034 (a 7.89% CAGR), according to IMARC Group
• The global medical spa market is forecast to grow from USD 23.29 billion (2025) to USD 47.17 billion by 2031, a 12.48% CAGR, according to Mordor Intelligence
• Asia-Pacific is the fastest-growing medical spa region globally, at a 14.52% CAGR through 2031
• AHPRA’s September 2025 advertising overhaul caps non-compliant ads at $60,000 (individual) to $120,000 (body corporate) per breach, a direct cost of growing into this market the wrong way

Dedicated aesthetic clinics in Australia are growing at a 13.02% compound annual growth rate through 2031, according to Mordor Intelligence’s Australia Aesthetic Devices Market report. That’s faster than hospitals, faster than the overall device market, and fast enough that the report specifically calls out clinics as the segment “moving the revenue centre of gravity away from hospitals.”

Here’s the thing: a clinic growing into that demand curve is also walking into the strictest advertising rulebook AHPRA has ever issued. The market and the compliance risk are expanding at the same time, in the same channels.

Below is the full data picture: how big the medispa market actually is in Australia right now, which segment is outgrowing the rest, and what a clinic needs to get right before it spends a dollar chasing that growth.

How Big Is Australia’s Medispa Market, Really

“Medispa market” gets used loosely, so it helps to separate the two figures that actually get reported for Australia.

The narrower one is the aesthetic devices market itself, the machines and equipment clinics buy: lasers, body-contouring devices, energy-based skin treatment platforms. Mordor Intelligence puts that market at USD 238.77 million in 2025, rising to USD 262.24 million in 2026, and forecasts it will reach USD 419.18 million by 2031, a 9.83% CAGR over that period.

The broader figure is Australia’s medical aesthetics market as a whole, which IMARC Group values at USD 396.4 million in 2025, forecast to reach USD 784.8 million by 2034, a 7.89% CAGR from 2026. That figure covers services and treatment spend, not just equipment, which is why it’s the larger of the two.

Neither number is the headline here. The headline is which segment inside that market is growing fastest, and that’s where dedicated clinics come in.

Takeaway: whichever way you slice it (devices or services), Australia’s medispa category is on track to roughly double within the next five to nine years.

Clinics Are Outgrowing Hospitals

Mordor Intelligence’s end-user breakdown is the more interesting number for anyone running a clinic rather than a hospital cosmetic unit. Hospitals held 41.55% of the Australian aesthetic devices market by revenue in 2025, still the largest single end-user category. That leaves 58.45% of the market split across dedicated aesthetic clinics, home care settings, and other end users, and the report forecasts that non-hospital side expanding fast: dedicated aesthetic clinics specifically at a 13.02% CAGR through 2031, well ahead of the 9.83% growth rate for the market overall.

That gap matters. A segment growing 3.19 percentage points faster than its own market for six straight years doesn’t stay a minority share for long.

Zooming out to the global picture puts the Australian clinic number in context rather than isolation. Mordor Intelligence’s global medical spa market report forecasts growth from USD 23.29 billion in 2025 to USD 47.17 billion by 2031, a 12.48% CAGR, with Asia-Pacific singled out as the fastest-growing region worldwide at 14.52% through 2031. Australia’s 13.02% clinic-segment growth sits inside that regional trend: faster than the 12.48% global medical spa average, a touch behind the 14.52% Asia-Pacific pace, and well ahead of the 7.89% CAGR forecast for Australia’s broader medical aesthetics services market (IMARC Group).

Takeaway: the fastest-growing part of Australia’s medispa market isn’t the market as a whole, it’s the dedicated clinic segment specifically, and it’s growing roughly in line with what’s happening across the rest of the Asia-Pacific region.

What’s Driving Clinics Into That Growth Curve

Three forces show up consistently across the market research: rising demand for minimally invasive treatments over surgical ones, more clinics positioning injectables and skin treatments as routine maintenance rather than one-off luxury spend, and consumer comfort with laser, body-contouring, and energy-based devices growing faster than comfort with surgical procedures. None of that is unique to Australia, but it’s arriving here on the same 12-13% growth trajectory the rest of the region is seeing.

What is unique to Australia is the regulatory environment those clinics are scaling into. AHPRA’s advertising guidelines for higher-risk non-surgical cosmetic procedures took effect on 2 September 2025, and the maximum financial penalty per offence now sits at $60,000 for an individual practitioner and $120,000 for a body corporate, up from $5,000 and $10,000 respectively before the overhaul. Testimonials, unedited before-and-after photography without “results may vary” disclaimers, and influencer endorsement arrangements are all squarely inside scope.

A clinic chasing a 13% growth segment cannot afford to fund that growth with advertising that breaches the rules on day one. If you haven’t checked your current site and ad copy against the 2025 rules, RockingWeb’s free AHPRA website compliance audit reviews it line by line and flags what needs to change before the next campaign goes live.

Takeaway: the market is growing faster than most clinics’ marketing has adapted to the new rules, which is exactly the gap that gets expensive first.

Building a Website and Marketing System for This Growth

A clinic segment growing at 13.02% a year needs a website and booking system that can absorb that growth without the compliance side falling behind the growth side. That’s a different brief to a template site bought off the shelf three years ago, before the September 2025 guidelines existed.

RockingWeb designs and rebuilds AHPRA and TGA-compliant cosmetic clinic websites from the first wireframe, so a clinic scaling into this market isn’t retrofitting compliance after a complaint lands. For clinics that want the website, the compliant ad copy, and the ongoing monitoring handled as one system rather than three separate vendors, ClinicPipeline is built specifically for that brief.

Data sources: Mordor Intelligence, Australia Aesthetic Devices Market (2026–2031 forecast) and Medical Spa Market (global, 2026–2031 forecast); IMARC Group, Australia Medical Aesthetics Market (2026–2034 forecast); AHPRA, Guidelines for advertising a regulated health service and Guidelines for advertising higher-risk non-surgical cosmetic procedures (effective 2 September 2025).

RockingWeb builds AHPRA-compliant websites and marketing systems for Australian cosmetic clinics. Get a free compliance audit or talk to us about your clinic’s marketing.